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Abstract
 Background : Reporter genes are widely used in biology and only a limited number are available. We present a new 
reporter gene for the localization of mammalian cells and transgenic tissues based on detection of the bglA (SYNbglA) 
gene of Caldocellum saccharolyticum that encodes a thermophilic β-glucosidase.
Results: SYNbglA was generated by introducing codon substitutions to remove CpG motifs as these are associated 
with gene silencing in mammalian cells. SYNbglA expression can be localized in situ or detected quantitatively in 
colorimetric assays and can be co-localized with E. coli β-galactosidase. Further, we have generated a Cre-reporter 
mouse in which SYNbglA is expressed following recombination to demonstrate the general utility of SYNbglA for in vivo 
analyses. SYNbglA can be detected in tissue wholemounts and in frozen and wax embedded sections.
Conclusions: SYNbglA will have general applicability to developmental and molecular studies in vitro and in vivo.
Background
A fundamental technique in biological research is the use
of reporter genes to track cells or tissues in developmen-
tal studies, to quantify or recognize gene expression from
defined cis-regulatory elements and to normalise for dif-
ferential uptake of DNA or delivery vectors in transfec-
tion experiments in vitro [1-4]. The most frequently used
reporters are Escherichia coli lacZ gene encoding β-galac-
tosidase (βgal), the green fluorescent protein (GFP) of
Aequorea victoria and to a lesser degree human placental
alkaline phosphatase [3,5,6]. In transgenic studies GFP
tends to be the reporter of choice for studies at single cell
or intracellular resolution or where viable cells need to be
isolated by fluorescence activated flow sorting (FACS).
Histochemical detection of lacZ is still widely used at the
single cell/tissue level of resolution especially where visu-
alization is in wholemounts of tissues or embryos. Here
we present a new reporter protein for cellular and whole
organism studies that is validated in vitro and by generat-
ing a Cre-reporter mouse in which the reporter is
detected in histological sections following induction of
Cre recombinase. This new reporter gene, termed SYNb-
glA, is based on the bglA  gene (GenBank: Accession
X12575), of the thermophilic bacterium Caldocellum sac-
charolyticum that encodes a β-glucosidase (βglu) thermo-
stable to 85°C [7].
Results
A mammalian expression construct in which the sub-
cloned C. saccharolyticum bglA gene is regulated from
the human elongation factor 1α (EF1α) promoter was
generated to create pEFbglA. For comparison, lacZ was
also subcloned to generate pEFlacZ. The EF1α promoter
was chosen as, unlike powerful viral promoters such as
the cytomegalovirus immediate early promoter (CMV
IE1), it does not tend to undergo silencing over time [8].
Following transient transfection cells expressing thermo-
stable βglu could be detected using BCI-glu in fixed cul-
tures with or without heat-treatment (65°C for 20 min;
data not shown). Colonies of NIH 3T3 cells transfected
with pEFbglA and pEFlacZ were isolated. βglu expression
remained detectable after heat treatment unlike βgal
which was heat inactivated (Figure 1a-d). To establish if
βgal and βglu can be co-localized stable clones separately
expressing either reporter were derived and mixed in 1:1
ratio and cultured together for 1-2 days prior to fixation
and staining with BCI-glu and Magenta-gal at 37°C. Indi-
vidual cells in the co-cultures stained with one substrate
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only and showed no cross-reactivity demonstrating the
potential to visualize these two reporters simultaneously
(Figure 1e).
After several passages, cultures derived from bglA+
clones in which all cells stained positive for βglu activity,
exhibited large numbers of unstained cells. Such a 'silenc-
ing effect' has been reported in experiments with the E.
coli  lacZ  gene [9]. Silencing of lacZ  is ameliorated by
changing its sequence to minimize the number of CpG
dinucleotides that are targets for methylation in mamma-
lian cells [9]. The bglA coding sequence contains 109 CpG
dinucleotides. Consequently, we undertook to resynthe-
size bglA such that the nucleotide sequence was depleted
for CpG dinucleotides and the codon sequence was
biased towards mammalian usage. A nuclear localization
s i g n a l  w a s  a l s o  a d d e d  a s  a  5 '  f u s i o n  ( F i g u r e  2 a ) .  T h e
reporter gene thus generated was termed SYNbglA (Gen-
Bank: Accession AY528410).
SYNbglA  was subcloned to generate pCMV-SYNbglA
that was cotransfected with pSV2neo into 293 cells and
G418 resistant clones obtained. The CMV promoter was
selected as a more robust test of the resistance of SYNb-
glA  t o  s i l e n c i n g .  F o u r  c l o n e s  w e r e  e x p a n d e d  a n d  a l l
expressed the altered βglu (SYNβglu) strongly and
homogenously as evaluated by BCI-glu staining. The
clones were serially passaged (cultures approaching con-
fluency were split 1:4 to 1:8 every 2 or 3 days) and contin-
uously evaluated for expression by staining with BCI-glu.
No reduction in the proportion of cells stained or in their
intensity was observed up to passage 40, the highest anal-
ysed (Figure 2b). We conclude that SYNbglA is not prone
to the gene-silencing phenomenon observed with bglA
and reported with unmodified lacZ [9,10].
βgal expression can be quantified by detecting cleavage
of O-nitro-phenyl-galactoside conjugated sugars in colo-
rimetric assays. We confirmed that SYNβglu expression
is quantifiable with ONP-glucopyranoside (not shown).
This method was then used to gain insight into the func-
tional stability of SYNβglu compared to βgal. Both pro-
teins were expressed inducibly in stably derived clones of
293EcR cells (engineered to express a heterodimeric tran-
scriptional transactivator that only binds to the DNA
binding domain present in an inducible promoter in the
presence of Pronesterone A, an ecdysone analogue) [11].
The rate at which reporter enzyme activity decayed fol-
lowing withdrawal of Pronesterone A was determined by
harvesting treated cells daily for 6 days. Following the
cessation of induced transcription, the rate of decay for
SYNβglu is similar to that of βgal, with a 50% reduction in
activity observed at 2.65 days and 2.33 days, respectively,
suggesting that they have similar stabilities within cells
(Figure 3).
In contemporary studies of gene function in vivo, genes
are not only deleted or overexpressed constitutively but
conditionally mutagenized using site-specific recombi-
Figure 1 Detection of β-glucosidase. Clones of NIH 3T3 cells ex-
pressing bglA or LacZ: β-glucosidase (βglu) stained with BCI-glu (a, b); 
β-galactosidase (βgal)stained with BCI-gal (c, d); mixture of cells shown 
in a-d and stained with BCI-glu and Magenta-gal (e). Clones (b, d) re-
ceived prior heat treatment (65°C, 20 min) showing that βglu (b) is still 
detectable histochemically while βgal (d) is not. In a mixed population, 
simultaneous incubation with both substrates results in cell autono-
mous staining for only one enzyme (e). Bars are 50 μm.
Figure 2 Genesis and validation of SYNbglA. (a) Schematic of the 
nucleotide changes introduced to the bglA sequence to generate SYN-
bglA. Substitutions to introduce preferred mammalian codon usage 
(red infill) or remove CpG dinucleotides (green infill) are shown. 5'and 
3'fusion elements (nuclear localization signal and cloning sites) are also 
shown (blue infill). (b) Detection of SYNbglA. BCI-glu stained clone of 
293 cells obtained after transfection with CMV-SYNbglA showing in-
tense nuclear localized and weaker cytoplasmic β-glucosidase up to at 
least passage 40. Bar is 50 μm.McCutcheon et al. BMC Biology 2010, 8:89
http://www.biomedcentral.com/1741-7007/8/89
Page 3 of 8
nases such as Cre [12,13]. Reporter lines for recombinase
activity are necessary to determine the timing, spatial
regulation and tissue specificity of recombinase expres-
sion [14]. Consequently, we decided to generate an alter-
native reporter line for assessing Cre activity by targeting
the ubiquitously expressed murine ROSA26 locus with
SYNbglA placed downstream of a floxed STOP cassette to
create a line named R26(SYNbglA)R (Figure 4). Frozen
sections and intestinal wholemounts from adult
R26(SYNbglA)R and non transgenic animals were analy-
sed for βglu activity using BCI-glu. Tissues from
R26(SYNbglA)R and non transgenic animals showed
identical staining patterns with all (including liver,
oesophagus, bladder, pancreas, muscle and heart) except
small intestine showing no staining due to background
enzymatic activity. In the small intestine, in both cases,
the positive staining was associated with the epithelial
brushborder and could be prevented by incubation at
65°C for 20 min prior to incubation in BCI-glu (Figure 5a,
b). These results indicate that there is no background
expression from the targeted allele and that detectable
endogenous βglu is only present in the small intestine.
In order to functionally test the R26(SYNbglA)R line it
was mated to two different Cre expressing lines, PGKcrem
and Ahcre. PGKcrem  is expressed from a maternally
inherited transgene that is expressed during the diploid
phase of oogenesis resulting in complete recombination
at loxP flanked cassettes even where PGKcrem  is not
inherited [15]. Male R26(SYNbglA)R mice were crossed
with PGKcrem females and the offspring analysed around
t h e  t i m e  o f  w e a n i n g .  T i s s u e s  w e r e  e x c i s e d ,  f i x e d  a n d
stained as wholemounted tissues in BCI-glu for 48 h. Tis-
Figure 3 Decay curves showing loss of reporter enzyme activity 
following removal of Pronesterone A from stable clones of 
293EcR cells expressing SYNβ-glu (magenta square) and β-gal 
(blue diamond). Data was plotted as mean ± standard error of mean 
for SYNβglu (n = 4) and βgal (n = 2), where n = number of experiments 
per time point. Exponential decay curves were fitted, indicating half-
lives of 2.65 days (R2 = 0.913) and 2.33 days (R2 = 0.969) for SYNβglu and 
βgal, respectively.
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Figure 4 Schematic of gene targeting at the ROSA26 locus to 
generate R26(SYNbglA)R. Shown are: the ROSA26 locus (top); the tar-
geting construct containing the loxP-PGKneo-loxP SYNbglA cassette 
(mid), arrows represent loxP sites; the targeted locus (bottom). Target-
ed clones were confirmed by Southern blotting of EcoR1 digested ge-
nomic DNA with the probe shown to generate 15 kb and 8.4 kb bands 
from the wild type and targeted alleles, respectively
EcoRV EcoRV EcoR1 NheI SacII
Exon 1 Exon 2
EcoR1
ROSA26
Probe
Probe R26(SYNbglA)R SA
PGKneo.pA SYNbglA
EcoRV SacII EcoR1
Exon 1
PGKpuro
EcoR1 EcoR1 EcoRV EcoR1
Exon 2
5  TA 3.0 kb PGKpuro
SA
PGKneo.pA SYNbglA
NheI
EcoR1
pROSA-MCS13-puro
3  TA 10.0 kb
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Exon 2
Figure 5 Histochemical detection of β-glucosidase activity in 
mouse tissues. (a, b) Cryostat sections of snap frozen small intestine 
from non-transgenic mice stained with BCI-glu. (a) Endogenous activ-
ity in the villus brush-border. (b) No activity following incubation at 
65°C for 20 min. (c-i) BCI-glu staining of tissues from R26SYNbglAR (left 
of panel) and PGKcrem/R26SYNbglAR (right of panel) mice: (c) heart and 
thymus, (d) spleen and pancreas, (e) kidney, (f) skeletal muscle, (g) liver, 
(h) glandular stomach and (i) brain. (j, k) Small intestinal wholemounts 
heat treated at 65°C and stained with BCI-glu from: (j) untreated Ahcre/
R26SYNbglAR; (k) β-napthoflavone treated Ahcre/R26SYNbglAR mice (4 
weeks post induction), showing detectable enzyme activity only in (k). 
(l-o) Wholemount of colon from an Ahcre/R26SYNbglAR mouse pre-
pared 16 weeks after β-napthoflavone treatment and stained with 
Mag-glu (p, proximal; d, distal). (l) Extensive recombination occurs 
throughout as indicated by magenta staining but becomes increas-
ingly variegated towards the distal end. (m-o) Shows enlargements of 
areas indicated by arrows. Punctate magenta staining corresponds to 
individual colonic crypts. Bars: A, B 200 μm, C-O 1 cm.McCutcheon et al. BMC Biology 2010, 8:89
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sues from age-matched mice not crossed to PGKcrem
mice were also prepared. In all tissues of mice obtained
from the R26(SYNbglA)R/PGKcrem intercross, including
heart, thymus, spleen, pancreas, kidney, skeletal muscle,
liver, stomach and brain, there was intense staining with
BCI-glu, where there was none in the control tissue. This
demonstrates that SYNβglu expression is sustained in
diverse tissue types following cre-mediated activation
(Figure 5c-i).
Ahcre is a mouse line in which Cre recombinase is con-
ditionally expressed from the rat cytochrome P450 IA1
promoter in several gastrointestinal tissues, following
treatment with the inducing agent β-napthoflavone [16].
The Ahcre line was originally validated with the R26R
reporter line, in which lacZ  is expressed from the
ROSA26 locus following cre-mediated recombination,
allowing the known pattern of recombination to be com-
pared with that obtained in Ahcre/R26(SYNbglA)R mice.
Thus, Ahcre/R26(SYNbglA)R were either left untreated
or treated with five daily intraperitoneal injections of 80
mg/kg β-napthoflavone to activate transcription of cre
and mediate excision of the stop cassette allowing expres-
sion of SYNbglA (Figure 5j, k). There was very a very low
level of background recombination in the target tissues of
untreated adult animals (Figure 5j). After induction, there
was near complete recombination with extensive expres-
sion of SYNβglu that could be detected with BCI-glu in
small intestinal wholemounts (Figure 5k). In the colon of
induced Ahcre/R26(SYNbglA)R mice there was extensive
recombination that was maximal proximally and became
increasingly mosaic towards the anus (Figure 5l-o). In
both untreated and treated mice the pattern of recombi-
nation was identical to that observed previously in
Ahcre/R26R mice although overall the extent of recombi-
nation as determined by expression of SYNbglA  seems
greater in more distal regions of the intestine [16].
Increasingly transgenic experiments require the simul-
taneous application of two or more reporter genes. We
wanted to establish if SYNβglu can be co-localized with
βgal in tissues. In order to achieve this we chose to anal-
yse the intestinal epithelium and exploit the known clon-
ality of intestinal crypts [17]. Ahcre and reporter strains
R26R and R26(SYNbglA)R were intercrossed to generate
animals carrying all three modifications (Ahcre/R26R/
R26(SYNbglA)R mice). These were injected with a single
dose of β-napthoflavone to induce Cre submaximally
such that mosaic patterns of recombination resulted. The
intestines were then analysed for expression of both βgal
and SYNβglu after 12 weeks, a time by which the process
of crypt monoclonal conversion is largely complete [18].
Intestinal wholemounts or cryostat sections were stained
first for βgal (6 h, 37°C) and then, after heat-treatment,
for SYNβglu as described in the Methods section using
BCI-gal and Mag-glu, respectively. Individual and clus-
ters of stained crypts could be clearly identified and could
be related to either reporter expressed alone or occasion-
ally both together (Figure 6a-e).
In order to determine if the introduced SYNβglu could
be detected in sections processed for histology in paraffin
wax blocks, different fixatives and protocols were tested.
Liver, pancreas, bladder and small intestinal samples
from Ahcre/R26(SYNbglA)R mice induced with β-
napthoflavone 1-6 weeks previously were fixed in various
fixatives for 1-6 h, processed through an ascending series
o f  e t h a n o l s ,  x y l e n e  a n d  i n t o  p a r a f f i n  w a x  a t  6 5 ° C  f o r
embedding. Five micrometer sections were cut, dewaxed
in xylene and rehydrated before incubation with BCI-glu
Figure 6 Co-localization of βgal and SYNβglu in cryostat sections 
of intestine from Ahcre/R26R/R26(SYNbglA)R mice. Colonic epithe-
lium showing (a) transverse and (b-d) longitudinally cross cut crypts. (a) 
Shows a mixture of staining patterns with some crypts unstained 
(white), some being stained only with BCI-gal (blue, cytoplasmic) or 
Mag-glu (magenta, nuclear) and others staining for both. (b-d) Shows 
selected crypts staining for both BCI-gal and Mag-glu (b), Mag-glu only 
(c), BCI-gal only (d). (e) Showing cross cut small intestinal villus with 
several migration streams (originating from multiple crypts) present. 
Blue arrows, BCI-gal staining only; magenta arrows, Mag-glu staining 
only; asterices, combined BCI-gal and Mag-glu staining). Bars are 50 
μm.McCutcheon et al. BMC Biology 2010, 8:89
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at 37°C. Clear nuclear localized histochemical product
was found in patterns identical to that observed with cry-
ostat sections as described above (Figure 7a and 7b). The
main determinant of staining intensity was the fixation
protocol with the best results achieved after 1 h fixation
with 2%formalin/0.2% glutaraldehyde.
In order to test whether or not SYNβglu can be local-
i z e d  w i t h  o t h e r  m a r k e r s ,  w e  p e r f o r m e d  i m m u n o h i s -
tochemistry specific for intestinal cell types in tissue
sections already stained for BCI-glu (either for 2 days at
37°C or overnight at 65°C). Villus enterocytes were easily
identified in such sections on the basis of their positive
staining for villin as were intestinal goblet cells on the
basis of staining for muc2 (Figure 7c and 7d).
Discussion
The βglu encoded by SYNbglA is an easily detected and
stable protein that seems an ideal cell marking reporter
molecule. It has potential application to cell and molecu-
lar studies where gene expression has to be localized. Its
potential applications in vivo include studies during
development and in the adult where gene expression
from defined promoter elements have to be detected or
for the fate mapping of tissues or individual cells, for
example in clonal studies [19,20].
Like βgal expression levels of SYNβglu can be quanti-
fied using colorimetric substrates. Such assays are rou-
tinely used for normalizing for vector uptake in
transfection experiments with the stability of βgal making
it suitable for this purpose. However, such colorimetric
assays are relatively insensitive and, as has been pointed
out previously for βgal, chemiluminescent substrates can
greatly increase sensitivity [3]. Appropriate chemilumi-
nescent substrates are available for the detection of
SYNβglu but, to date, we have not attempted to apply
them. However, the ultimate limit on sensitivity for βgal is
the presence of background enzymatic activity from
endogenous, mammalian β-galactosidases and it is likely
that the ability to destroy such background by heat inacti-
vation will mean that SYNβglu has an enhanced sensitiv-
ity over that of βgal [21].
SYNβglu may have advantages over E. coli βgal for cel-
lular localization in some experimental settings. The
thermostability of SYNβglu allows it to be visualized in
high-resolution sections from paraffin wax embedded
tissues. The size of the coding sequence for SYNbglA is
1.2 kb compared to 3.1 kb for lacZ. This smaller size is
advantageous for viral delivery vectors where cloning of
large inserts is problematic.
The similarity of SYNβglu and βgal both in terms of
processing requirements for visualization and the relative
stabilities of the two proteins, together with the observa-
tion that they can be can co-localized, suggests that they
may be used in tandem in compound genetically modi-
fied transgenic animals where gene expression changes
are being effected. The compatibility of SYNβglu and βgal
for dual detection may become especially significant as
transgenic analyses become more elaborate. For example,
a stem cell marker gene (Lgr5) has been validated in mice
by localizing stem cells using an enhanced yellow fluores-
cent protein targeted to the Lgr-5 locus along with a
Tamoxifen activated Cre recombinase [22]. Recombina-
tion mediated by the latter is recognized in crosses to
R26R mice as clones of cells expressing βgal. A recent
study of neuronal function combines use of GFP and
human alkaline phosphatase to allow simultaneous detec-
tion of cell bodies, neurites and presynaptic sites and
envisages the potential to also detect βgal in crosses to
mutant strains [23]. In this regard, SYNbglA will add to
the limited platform of available reporters. The R26(SYN-
bglA)R mice described here will further permit detailed
analysis of the pattern of Cre activity in mouse models in
which recombination is restricted to specific cell types
and tissues and to different stages of development.
Figure 7 Ahcre/R26SYNbglAR mice with tissues processed for 
paraffin wax embedding and stained with BCI-glu (37°C) for 48 h 
as described in the Methods section. In liver (a) and small intestine 
(b) clear nuclear localized staining is evident. Small intestinal sections 
were further processed for immunohistochemistry with antibodies to 
muc2 (c) or villin (d) identifying goblet cells and absorptive entero-
cytes, respectively. Bars are 50 μm.McCutcheon et al. BMC Biology 2010, 8:89
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Conclusions
SYNβglu is an easily detected reporter protein that has a
variety of applications in vitro and  in vivo where cell
tracking, accurate localisation and high sensitivity is
required. SYNβglu may offer some advantages to the E.
coli βgal but the ability to use these two reporter systems
together suggests that they will complement each other
and will be used in tandem. The Cre-reporter animals
described here demonstrate the applicability of SYNβglu
to transgenic tissues and in the analysis of Cre mediated
recombination.
Methods
Plasmid cloning
The  bglA  sequence was initially PCR amplified from
pNZ1065 (gift of Dr D Love) and subcloned into pCR3
(Invitrogen) using primers (5' ttccatggGGATCCtaagtttc-
ccaaaaggatttttgtgg 3' and 5' ttAGATCTgtcgacttac-
gaattttcctttatatactg 3') designed to introduce a consensus
translation start sequence (bold) and flanking restriction
sites (caps) for subsequent cloning [7,24]. This bglA frag-
ment was subcloned into pEF1alpha [25] to generate an
expression construct (pEFbglA) containing the human
type 1α elongation factor promoter and SV40 polyadeny-
lation sequence. In order to allow a comparison, the
equivalent lacZ construct (pEFlacZ) was also made by
conventional subcloning (cloning details available on
request). The SYNbglA and lacZ cassettes were also sub-
cloned into pIND (Invitrogen, CA, USA) containing five
ecdysone response elements upstream of a Drosophila
minimal promoter. Additional cloning details are avail-
able upon request.
In order to generate the final gene targeting construct,
conventional cloning was performed to make a cassette
comprising loxP-PGKneo.pA-loxP  SYNbglA.pA which
was subcloned into pROS-MCS-13 [26] containing the
two arms of ROSA26 locus homology. Additional cloning
details are available upon request.
Cell lines
Mouse NIH 3T3 and human 293-EcR cells were obtained
from the American Type Culture Collection and Invitro-
gen, respectively, and were maintained in standard tissue
culture media (Dulbecco's Modified Eagle's Medium)
containing 10% fetal calf serum. Cells were transfected
using the Stratagene MBS kit. Where cotransfection was
required for the purpose of antibiotic selection the test
plasmid was cotransfected (10:1 ratio) with pSV2neo
(Clontech, CA, USA) followed by G418 selection at 1 mg/
mL.
Synthesis of SYNbglA
SYNbglA was chemically synthesized by Bionexus using
their proprietorial method (Bionexus Inc, CA, USA http:/
/www.bionexus.net/)
Gene targeting
Embryonic stem cell manipulation procedures were per-
formed by the Gene Targeting Service, Babraham Insti-
tute (Cambridge, UK). E14 129Ola ES clones were
selected with G418 and colonies initially screened by
polymerase chain reaction using primers anchored 5' to
the shorter targeting arm (R26TOPV: 5' ggtagtggggtcgac-
tagatgaaggagagcc 3') and at the introduced splice acceptor
(R26SAmut: gtcctcaaccgcgagctgtg) which amplified a
unique 4kb band. Two clones were selected following fur-
ther screening by Southern blotting using a probe located
5' to the targeting vector as described previously [26].
These clones, C8 and C10, were microinjected into blas-
tocysts and the resultant chimeras used to establish
R26(SYNbglA)R mice. Both clones were evaluated for
expression of reporter following induction of Cre in dou-
ble transgenic Ahcre/R26(SYNbglA)R mice and were
found to behave identically.
Enzyme histochemistry
Cellular localization for lacZ in tissue culture plates was
performed by routine methods [27] that were modified
for detection of bglA expression as needed. Essentially,
plates were washed in phosphate buffered saline (PBS)
before fixation in 2% formaldehyde/0.1% glutaraldehyde
in PBS. After washing with PBS plates were incubated
with 0.04% conjugated sugar substrates [5-bromo-4-
chloro 3-indolyl-β-D-galactopyranoside (BCI-gal, No.
MB1001), 5-bromo-6-chloro-3-indolyl-β-D-galactopyra-
noside (Magenta-gal, No. M1141), 5-bromo-4-chloro 3-
indolyl-β-D-glucopyranoside (BCI-glu, No. MB1002), all
from Melford Laboratories, Suffolk, UK or 5-bromo-6-
chloro-3-indolyl-β-D-glucopyranoside (Magenta-glu, No.
31059, Glycosynth, Cheshire, UK)] containing potassium
ferrocyanide (4 mM), potassium ferricyanide (2 mM) and
magnesium chloride (1 mM) in PBS at the temperatures
stated.
Protein stability determination
The colorimetric assay for βgal and βglu was carried out
using a commercially available kit (No. E2000; Promega,
WI, USA) as per the manufacturers instructions, except
that the substrate containing solutions [o-nitrophenyl-β-
D-galactopyranoside (ONP-gal), Sigma No. N1127, o-
nitrophenyl-β-D-glucopyranoside (ONP-glu), Sigma No.
N8016] at a concentration of 1.33 mg/mL were prepared
independently. The absorbance of the cleaved substrates
at 420 nm was determined on a Tecan SpectraFluor Plus
plate reader.
The commercially available ecdysone inducibility sys-
tem was obtained including 293EcR cells that stably
express the VgRXR receptor (a heterodimer of ecdysone
receptor and retinoid X receptor) (Invitrogen, Scotland,
UK). In 293 EcR cells the heterodimer binds to an ecdy-
sone response element in pIND in the presence of Pron-McCutcheon et al. BMC Biology 2010, 8:89
http://www.biomedcentral.com/1741-7007/8/89
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testerone A. Clones of 293EcR cells were obtained by
selection with G418 following transfection with
pINDSYNbglA or pINDlacZ that contain a neo selection
cassette. Clones were screened for conditional expression
of βglu and βgal, respectively, in the presence of Pronest-
erone A (5 μM). For each reporter one clone was plated
out at low density in 2.5 cm2 replicated tissue culture
wells which were incubated in media containing Pronest-
erone A (5 μM) for 24 h. Triplicate wells for each clone
were harvested in lysis buffer (Promega, No. 397A) at 24
h intervals after PBS wash (x3). Cells harvested at the end
of Pronesterone A treatment were designated day 0. For
each lysate total protein concentration was determined
using a Pierce BCA kit (PerBio, No. 23227) and the vol-
umes analysed in the enzyme assay were normalized for
total protein content.
Treatment of animals
Homozygous Ahcre mice were crossed with R26(SYNb-
glA)R animals and offspring carrying both transgenes
selected for subsequent experiments. Ahcre mice were
genotyped as described and R26(SYNbglA)R mice by
polymerase chain reacton using a primer combination (5'
cagaaaggtagacggatttagcc 3'; 5' gggatacagaagaccaatgcaga3';
5' tcctcaaccgcgagctgtg 3') giving a 440 bp and 350 bp for
the wild type and targeted R26 loci, respectively [16]. For
induction of the Ah promoter, mice received interperito-
neal injections of 80 mg/kg β-napthoflavone (βNF;
Sigma) dissolved in corn oil (8 mg/mL) at the frequencies
stated and controls received either no treatment or corn
oil only.
Tissues and immunohistochemistry
Whole tissues for BCI-glu staining were dissected from
3-week-old mice and were sliced to present a cut facet for
histochemistry. Tissues were fixed in 4% paraformalde-
hyde for 2 h, washed in PBS and incubated in BCI-glu at
50°C for 48 h. Intestinal wholemounts from Ahcre/
R26(SYNbglA)R animals were prepared lumenal side up
as described previously [16] except that they were fixed in
ice cold 2% formaldehyde/0.2% glutaraldehyde in PBS
(pH7.4) for 1 hour prior to overnight incubation in BCI-
glu (as described above) substrate at room temperature.
For frozen sections small pieces of intestine were snap
frozen in liquid nitrogen and cryostat sectioned. Slides
were air dried, fixed for 5 minutes in ice cold 2% formal-
dehyde/0.2% glutaraldehyde in PBS (pH7.4) for 10 min,
before transferral to BCI-glu. For heat inactivation sec-
tions were incubated in PBS at 65°C for 10-20 min prior
to incubation in BCI-glu. Tissues processed for histology
were immersed in the fixatives for the length of time
stated and processed into paraffin wax blocks using a Cit-
adel tissue processor (ThemoShandon, Cheshire, UK)
with freshly prepared dehydrating ethanols (x1 70%, 30
min; x1 90%, 30 min; x3 100%, 30 min each), xylene (x3,
20 min each) and wax (x2, 30 min each). Sections were
cut at 3-5 μm, dewaxed and rehydrated into PBS prior to
immersion into BCI-glu, prepared as above, and incu-
bated at 37°C (48 h) or 65°C (overnight).
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